Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 1/20 | 0.47 |
| ▸ | KDM1A | O60341 | 3/20 | 0.43 |
| ▸ | BACE1 | P56817 | 4/20 | 0.42 |
| ▸ | CTSD | P07339 | 2/20 | 0.42 |
| ▸ | GRPR | P30550 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | KDM5A | P29375 | 1/20 | 0.40 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.40 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.40 |
| ▸ | GHSR | Q92847 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | TFPI | P10646 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 1/20 | 0.38 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30601031 | 0.93 | CALCRL (0.50) | CALCRLKDM1ABACE1CTSDGRPR | |
| SCHEMBL31475694 | 0.90 | CALCRL (0.46) | CALCRLKDM1ABACE1CTSDGRPR | |
| SCHEMBL29568733 | 0.84 | BACE1 (0.48) | CALCRLKDM1ABACE1CTSDMAOB | |
| SCHEMBL30363512 | 0.84 | FOLH1 (0.42) | CALCRLGHSR | |
| SCHEMBL30311313 | 0.84 | KEAP1 (0.47) | CALCRLKDM1ABACE1CTSDGRPR | |
| SCHEMBL30844409 | 0.83 | KDM1A (0.47) | CALCRLKDM1ABACE1CTSDMAOB | |
| SCHEMBL30844341 | 0.83 | CALCRL (0.42) | CALCRLKDM1ABACE1CTSDGHSR | |
| SCHEMBL30311449 | 0.83 | BACE1 (0.47) | CALCRLKDM1ABACE1CTSDMAOB | |
| SCHEMBL11576611 | 0.83 | CPB2 (0.41) | CALCRLKDM1ABACE1CTSDGHSR | |
| SCHEMBL11576618 | 0.83 | CPB2 (0.41) | CALCRLKDM1ABACE1CTSDGHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129126-A1 | LONG-LASTING HEPATITIS VIRUS ENTRY INHIBITOR | Chengdu AODA Biotechnology Co., Ltd (CN) | 2025-04-24 | — | — | US | disclosed |
| CN-118574640-A | Medicine and method for treating limited chronic hepatitis B by nucleoside (nucleotide) medicines | 上海贺普药业股份有限公司 | 2024-08-30 | — | — | CN | disclosed |